Latest 10-Q quarterly reports

Gemini Space Station, Inc. reported a net loss of $107.7 million for Q2 2026, with total revenue of $45.5 million, while operating expenses increased significantly.

Fifth Era Acquisition Corp I reports on its financial condition and ongoing efforts to identify and complete a business combination, with significant interest income offsetting operational expenses.

Karbon Capital Partners Corp. filed its Q2 2026 Form 10-Q, detailing its financial position as a SPAC, with net income driven by interest on its trust account investments and ongoing efforts to identify a business combination target.

Applied Energetics, Inc. filed its Q2 2026 10-Q, revealing a significant revenue decrease and widening net loss, while highlighting ongoing research and development and substantial going concern risks.

Forbright, Inc. reported a substantial decrease in net income and earnings per share for the second quarter of 2026 compared to the same period in 2025, driven by increased expenses and a higher provision for credit losses.

Ares Acquisition Corporation III, a SPAC, has filed its Form 10-Q for the quarter ended June 30, 2026, detailing its formation activities, initial public offering, and financial status prior to a business combination.

American Shared Hospital Services (ASHS) reported increased revenues for the second quarter and first half of 2026, but faces substantial doubt about its ability to continue as a going concern due to ongoing covenant breaches with lenders and a new subordinated debt agreement with an insider.

Biofrontera Inc. reported a 32.9% increase in product revenue for Q2 2026, driven by higher Ameluz sales, but continues to face substantial doubt regarding its going concern status and significant operational challenges from regulatory actions.

Edesa Biotech's Q3 2026 Form 10-Q reveals a substantial increase in net loss and operating expenses, alongside persistent concerns regarding its ability to continue as a going concern.

Archimedes Tech SPAC Partners III Co. filed its Form 10-Q for the quarter ended June 30, 2026, detailing its financial position as a SPAC with substantial trust account assets and no operating revenue.

Tempest Therapeutics' Q2 2026 Form 10-Q reveals significant financial challenges, including substantial operating losses and a critical cash position, while also highlighting progress in its CAR-T therapy development.

Securitize Corp. (formerly Securitize Holdings, Inc.) filed its Form 10-Q for the quarter ended June 30, 2026, detailing its pre-operational status before a significant business combination that closed on July 1, 2026.

Archimedes Tech SPAC Partners II Co. filed its Q2 2026 Form 10-Q, detailing a substantial net loss and outlining progress on its proposed business combination with Forge Nano, Inc.

Richmond Mutual Bancorporation, Inc. reported its financial results for the second quarter ended June 30, 2026, showing increased net interest income and strategic merger completion.

Alliance Laundry Holdings Inc. announced a robust second quarter for 2026, showcasing significant year-over-year increases in net revenues and operating income, alongside a substantial reduction in debt.

GlobalTech Corporation filed an amendment to its Q1 2026 10-Q report to correct previously omitted disclosures regarding unregistered sales of equity securities.

Innventure, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing continued operational losses and significant liquidity concerns, while also reporting revenue growth in its Technology segment.

Park Dental Partners reported a 5.1% increase in Q2 revenue to $66.2 million, driven by acquisitions and reimbursement growth, but net income fell significantly to $1.35 million from $2.57 million year-over-year.

Entrepreneur Universe Bright Group reported a net loss for the second quarter of 2026, with revenues decreasing by 34.7% year-over-year, alongside significant internal control deficiencies.

Aether Holdings, Inc. reported a net loss of $1.34 million for Q3 2026, with total operating expenses increasing significantly, raising concerns about its going concern status.

CapsoVision, Inc. reported a 10% revenue increase for Q2 2026, but net losses widened significantly, raising concerns about its ability to continue as a going concern.

Legence Corp. reported a substantial increase in revenue for the second quarter of 2026, driven by strong performance in its Installation & Maintenance segment and recent acquisitions, though net losses widened due to increased operating expenses and impairments.

Petros Pharmaceuticals, Inc. reported a significant accumulated deficit and substantial doubt regarding its ability to continue as a going concern in its latest quarterly filing.

Fluent, Inc. reported an 8% revenue increase for Q2 2026, yet the company faces substantial doubt regarding its ability to continue as a going concern.

Idea Acquisition Corp. reports its financial position for the quarter ended June 30, 2026, detailing its cash reserves and operational expenses as it seeks a business combination.

Horizon Space Acquisition I Corp. reports a substantial going concern doubt due to its ongoing lack of operations, significant accumulated deficit, and insufficient working capital, despite extending its business combination deadline.

Health in Tech's Q2 results show a revenue decline and increased expenses, with a new carrier transition impacting operations and a significant convertible financing agreement announced.

Roadzen Inc. filed its Q2 2026 Form 10-Q, reporting a 49% increase in revenue but a widening net loss and significant increases in interest expenses and fair value losses on financial instruments.

Kraig Biocraft Laboratories, Inc. filed its Q2 2026 10-Q, revealing continued net losses and a substantial working capital deficiency, raising concerns about its ability to continue as a going concern.

ChampionsGate Acquisition Corporation reports on its financial condition and operational status for the quarter ended June 30, 2026, highlighting ongoing efforts to secure a business combination.